Keywords: Serodus, Roche, Licensing, Heart failure, RO1160637

Serodus buys rights to Roche drug for potential treatment of heart failure

Article | 14 December 2010

Print This

Norway’s Serodus has entered into a license agreement with Swiss drug major Roche (ROG: VX) for a selective ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in